Navigation Links
Azantis Launches Liposomal Glutathione and Vitamin C.
Date:10/31/2011

BOULDER, Colo., Oct. 31, 2011 /PRNewswire/ -- Azantis launched today two innovative liposomal products: reduced glutathione and vitamin C. Both oral supplements are formulated in liposomal form to maximize absorption and to minimize side effects. Azantis, a leading phospholipid manufacturer, markets the liposomal products to resellers targeting the health care practitioner channel.

The liposomal glutathione contains 500 mg reduced glutathione per recommended daily dose.  These liposomes are highly stable with a very tight particle size range.  These features optimize the bioavailability of the glutathione cargo.

Glutathione is the body's most important intracellular sulfur bearing antioxidant, and the body's prime defense against toxins and oxidation. Low glutathione blood levels are commonly associated with poor health.

The vitamin C liposomes are designed to minimize intestinal discomfort, since certain individuals have difficulty tolerating vitamin C therapy at the clinically relevant higher doses. The recommended daily dosage is 1,000 mg vitamin C.  The vitamin C, as well as the glutathione liposomal product, is in liquid form.

"Reduced glutathione in liposomal form is superior, because of the maximized absorption. Oral administration of supplemental liposomes, when compared to IV and injections, allows a more even dosing of once or possibly several times per day," said Mickey Schuett, Director of Sales at Azantis Inc. "These products target foremost health care practitioners and resellers that market to these practitioners. The potency of this advanced delivery form is less suitable for the direct to consumer market."

Consumer information about liposomal glutathione and liposomal vitamin C can be readily found on the internet.

About Azantis

Azantis is a biotech company located in Boulder, Colorado. The company specializes in discovery and extraction of bioactive molecules from sustainable marine and other biomass sources for use in food, nutraceutical, and pharmaceutical products. Azantis' product offerings include omega 3 phospholipids and phospholipid liposomes.

Contact Mickey Schuett, 303-502-2400 or http://www.azantis.com/contact-us/


'/>"/>
SOURCE Azantis
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Azantis Announces New Consumer Safety Program
2. Australias Prince of Wales Hospital Launches New Era of Targeted Lung Cancer Treatments with Elektas Advanced 4D Motion Management Technology
3. Global Strategic Marketing Key to Success in Oncology Launches in the Pharmaceutical Sector
4. FHSSA Launches New Campaign to Partner US Hospices with Programs in Sub-Saharan Africa
5. nContact, Inc. Launches New Corporate Websites
6. First Response Launches IVF Fundraising Resource for Those Trying for a Baby
7. CDC Launches Effort to Protect Cancer Patients From Infections
8. Mylan Launches First Generic Version of Exelon® Capsules in the U.K.
9. Gamma Pharmaceuticals, Inc., Launches Retail Promotions for Gamma Energy Gel™ in New York City and Houston
10. Arthrosurface Launches Worlds First Talus Resurfacing Implant for the Ankle
11. DYMO® Labeling Launches High-Resolution Identification Scanner for Health Records Processing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... HILL, N.C. , June 24, 2016 /PRNewswire/ ... healthcare decisions and regulators/payers have placed more emphasis ... new environment, patient support programs in the pharmaceutical ... for patients, medications. Consequently, pharmaceutical companies are focusing ... ensure they are providing products and services that ...
(Date:6/24/2016)... , June 24, 2016   Bay Area ... Network,s Dean Center for Tick Borne Illness ... and Rehabilitation, MIT Hacking Medicine, University of California, ... today announced the five finalists of Lyme ... disease.  More than 100 scientists, clinicians, researchers, entrepreneurs, ...
(Date:6/24/2016)... Va. , June 24, 2016 The ... set of recommendations that would allow biopharmaceutical ... (HCEI) with entities that make formulary and coverage decisions, ... the "value" of new medicines. The recommendations ... does not appear on the drug label, a prohibition ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson ... Recently, he has implemented orthobiologic procedures as a method for treating his patients. ... the first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons ...
(Date:6/24/2016)... Michigan (PRWEB) , ... June 24, 2016 , ... Those ... deal with these feelings, many turn to unhealthy avenues, such as drug or alcohol ... of Marne, Michigan, has released tools for healthy coping following a traumatic event. , ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, P.A. announced that ... chosen by their peers for this recognition are considered among the top 2 percent ... special honors as members of this year’s Legal Elite Hall of Fame: Miami ...
(Date:6/24/2016)... , ... June 24, 2016 , ... People across the ... Genome magazine’s Code Talker Award, an essay contest in which patients and their families ... to be presented at the 2016 National Society of Genetic Counselors (NSGC) Annual Education ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... actively feeding the Frederick area economy by obtaining investment capital for emerging technology ... past 2½ years that have already resulted in more than a million dollars ...
Breaking Medicine News(10 mins):